Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 766

1.

Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias.

Bao F, Munker R, Lowery C, Martin S, Shi R, Veillon DM, Cotelingam JD, Nordberg ML.

Mol Diagn Ther. 2007;11(4):239-45.

PMID:
17705578
2.

Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.

Amare PS, Baisane C, Saikia T, Nair R, Gawade H, Advani S.

Cancer Genet Cytogenet. 2001 Dec;131(2):125-34.

PMID:
11750052
3.

A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.

Cox MC, Maffei L, Buffolino S, Del Poeta G, Venditti A, Cantonetti M, Aronica G, Aquilina P, Masi M, Amadori S.

Am J Clin Pathol. 1998 Jan;109(1):24-31.

PMID:
9426514
4.

Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation.

Neumann F, Herold C, Hildebrandt B, Kobbe G, Aivado M, Rong A, Free M, Rössig R, Fenk R, Schneider P, Gattermann N, Royer-Pokora B, Haas R, Kronenwett R.

Eur J Haematol. 2003 Jan;70(1):1-10.

PMID:
12631253
5.

Correlation of cytogenetics, BCR-ABL PCR studies and fluorescence in situ hybridisation (FISH) in adult acute lymphoblastic leukaemia.

Campbell LJ, Martinow A, Michael PM, White JS, Rayeroux KC, Januszewicz EH.

Aust N Z J Med. 1999 Oct;29(5):707-12. Review.

PMID:
10630652
6.

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.

Hardling M, Wei Y, Palmqvist L, Swolin B, Stockelberg D, Gustavsson B, Ekeland-Sjöberg K, Wadenvik H, Ricksten A.

Med Oncol. 2004;21(4):349-58.

PMID:
15579919
7.

Assessment of the response to imatinib in chronic myeloid leukemia patients--comparison between the FISH, multiplex and RT-PCR methods.

Raanani P, Ben-Bassat I, Gan S, Trakhtenbrot L, Mark Z, Ashur-Fabian O, Itskovich S, Brok-Simoni F, Rechavi G, Amariglio N, Nagler A.

Eur J Haematol. 2004 Oct;73(4):243-50.

PMID:
15347310
8.

[Acute lymphoblastic leukemias with aberrations of BCR-ABL genes].

Parovichnikova EN, Savchenko VG, Verniuk MA, Vinogradova OA, Misiurin AV, Vorob'ev IA, Domracheva EV, Tikhonova LIu, Rukavitsyn OA, Rossiev VA, Kliasova GA, Turkina AG, Liubimova LS, Mendeleeva LP, Isaev VG.

Ter Arkh. 2005;77(7):11-6. Russian.

PMID:
16116902
9.

Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML.

Kim YJ, Kim DW, Lee S, Kim HJ, Kim YL, Hwang JY, Oh IH, Park YH, Lee YK, Min CK, Kim TG, Han TH, Min WS, Kim CC.

Eur J Haematol. 2002 May;68(5):272-80.

PMID:
12144533
10.
11.

[Monitoring bcr-abl mRNA levels by real-time quantitative RT-PCR in chronic myeloid leukemia patients after hematopoietic stem cell transplantation].

Qin YZ, Li JL, Zhu HH, Ruan GR, Li LD, Zhang Y, Xu LP, Liu DH, Liu YR, Huang XJ, Chen SS, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2006 Aug;27(8):511-4. Chinese.

PMID:
17172121
12.

Detection of BCRabl in Acute Leukemia by Molecular and Cytogenetic Methods.

Wells SJ, Phillips CN, Farhi DC.

Mol Diagn. 1996 Dec;1(4):305-313.

PMID:
10462577
13.

[The monitoring of residual disease for chronic myelogenous leukemia patients treated with imatinib mesylate: detection of T315I mutation in ATP binding site of BCR/ABL gene].

Miyanishi S, Umeki K, Hayashi T, Fukutsuka K, Okumura A, Kishimori C.

Rinsho Byori. 2003 Oct;51(10):1023-9. Japanese.

PMID:
14653203
14.

Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapy.

Tchirkov A, Giollant M, Tavernier F, Briançon G, Tournilhac O, Kwiatkowski F, Philippe P, Choufi B, Deméocq F, Travade P, Malet P.

Br J Haematol. 1998 Jun;101(3):552-7.

PMID:
9633901
15.

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia.

Olavarria E, Kanfer E, Szydlo R, Kaeda J, Rezvani K, Cwynarski K, Pocock C, Dazzi F, Craddock C, Apperley JF, Cross NC, Goldman JM.

Blood. 2001 Mar 15;97(6):1560-5.

16.
18.

[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].

Qin YZ, Ruan GR, Liu YR, Li JL, Fu JY, Wang H, Chang Y, Jiang B, Jiang Q, Jiang H, Qiu JY, Chen SS, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):1-5. Chinese.

PMID:
15946498
19.

Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.

Bolufer P, Sanz GF, Barragán E, Sanz MA, Cervera J, Lerma E, Senent L, Moreno I, Planelles MD.

Haematologica. 2000 Dec;85(12):1248-54.

20.

Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.

Ko BS, Tang JL, Lee FY, Liu MC, Tsai W, Chen YC, Wang CH, Sheng MC, Lin DT, Lin KH, Tien HF.

Am J Hematol. 2002 Dec;71(4):291-9.

Supplemental Content

Support Center